| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 56663 |
| 1 | ADALIMUMAB | 47251 |
| 2 | DUPILUMAB | 30477 |
| 3 | METHOTREXATE SODIUM | 14226 |
| 4 | METHOTREXATE | 14058 |
| 5 | TIRZEPATIDE | 12325 |
| 6 | EVOLOCUMAB | 10340 |
| 7 | DULAGLUTIDE | 9796 |
| 8 | PREDNISONE | 7127 |
| 9 | GALCANEZUMAB-GNLM | 6969 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMATROGON-GHLA | 765 | 0.6693 |
| 1 | KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE INJECTION | 119 | 0.6538 |
| 2 | MOTIXAFORTIDE | 33 | 0.3793 |
| 3 | LENACAPAVIR SODIUM | 105 | 0.2966 |
| 4 | GALCANEZUMAB-GNLM | 6969 | 0.2354 |
| 5 | GLATIRAMER ACETATE INJECTION | 702 | 0.1556 |
| 6 | OCRELIZUMAB AND HYALURONIDASE | 33 | 0.1398 |
| 7 | ASFOTASE ALFA | 1254 | 0.1376 |
| 8 | FREMANEZUMAB-VFRM | 1253 | 0.1175 |
| 9 | CABOTEGRAVIR | 889 | 0.1158 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 60586 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 30477 |
| 2 | GLP-1 Receptor Agonist [EPC] | 26177 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 13772 |
| 4 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 12325 |
| 5 | PCSK9 Inhibitor [EPC] | 11560 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11491 |
| 7 | Corticosteroid [EPC] | 11069 |
| 8 | Insulin Analog [EPC] | 10308 |
| 9 | Vitamin C [EPC] | 8611 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1254 | 0.1376 |
| 1 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 3 | 0.1111 |
| 2 | Recombinant Human Growth Hormone [EPC] | 1851 | 0.0880 |
| 3 | Melanocortin 4 Receptor Agonist [EPC] | 19 | 0.0856 |
| 4 | Cytolytic Agent [EPC] | 191 | 0.0828 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 30477 | 0.0740 |
| 6 | GLP-1 Receptor Agonist [EPC] | 26177 | 0.0682 |
| 7 | PCSK9 Inhibitor [EPC] | 11560 | 0.0648 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 997 | 0.0629 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 60586 | 0.0623 |